![Chi Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chi Li formerly worked at Editas Medicine, Inc., as Chief Regulatory Officer & Senior Vice President and Celularity, Inc. (United States), as Chief Regulatory Officer.
Dr. Li received his doctorate degree from Purdue University and Masters Business Admin degree from Rutgers University, Camden.
| Companies | Position | End |
|---|---|---|
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which produces allogeneic cells and tissues from postpartum placenta | General Counsel | - |
| EDITAS MEDICINE, INC. | General Counsel | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Rutgers University, Camden
 Rutgers University, Camden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which produces allogeneic cells and tissues from postpartum placenta | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
